No association between a candidate TCF7L2 variant and risk of breast or ovarian cancer

BMC Cancer

Volumn 9, Issue , 2009, Pages 312-

  Goode, Ellen L ^a   Szabo, Csilla ^a   Prokunina Olsson, Ludmila ^b   Vierkant, Robert A ^a   Fredericksen, Zachary S ^a   Collins, Francis S ^c   White, Kristin L ^a   Schmidt, Michele ^a   Fridley, Brooke L ^a   Couch, Fergus J ^a  

^a Mayo Clinic College of Medicine   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR 7 LIKE 2;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; RISK FACTORS; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN; YOUNG ADULT;

EID: 70349850357     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-312     Document Type: Article

References (21)

1. Reynisdottir I, Thorleifsson G, Benediktsson R, Sigurdsson G, Emilsson V, Einarsdottir AS, Hjorleifsdottir EE, Orlygsdottir GT, Bjornsdottir GT, Saemundsdottir J. Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2. Am J Hum Genet 2003, 73(2):323-335. 10.1086/377139, 1180371, 12851856.
2. Duggirala R, Blangero J, Almasy L, Dyer TD, Williams KL, Leach RJ, O'Connell P, Stern MP. Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. Am J Hum Genet 1999, 64(4):1127-1140. 10.1086/302316, 1377837, 10090898.
3. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, Helgason A, Stefansson H, Emilsson V, Helgadottir A. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006, 38(3):320-323. 10.1038/ng1732, 16415884.
4. Cauchi S, El Achhab Y, Choquet H, Dina C, Krempler F, Weitgasser R, Nejjari C, Patsch W, Chikri M, Meyre D. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med 2007, 85(7):777-782. 10.1007/s00109-007-0203-4, 17476472.
5. Cauchi S, Choquet H, Gutierrez-Aguilar R, Capel F, Grau K, Proenca C, Dina C, Duval A, Balkau B, Marre M. Effects of TCF7L2 polymorphisms on obesity in European populations. Obesity (Silver Spring) 2008, 16(2):476-482. 10.1038/oby.2007.77, 18239663.
6. Burwinkel B, Shanmugam KS, Hemminki K, Meindl A, Schmutzler RK, Sutter C, Wappenschmidt B, Kiechle M, Bartram CR, Frank B. Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study. BMC Cancer 2006, 6:268. 10.1186/1471-2407-6-268, 1665524, 17109766.
7. Agalliu I, Suuriniemi M, Prokunina-Olsson L, Johanneson B, Collins FS, Stanford JL, Ostrander EA. Evaluation of a variant in the transcription factor 7-like 2 (TCF7L2) gene and prostate cancer risk in a population-based study. Prostate 2008, 68(7):740-747. 10.1002/pros.20732, 18302196.
8. Hazra A, Fuchs CS, Chan AT, Giovannucci EL, Hunter DJ. Association of the TCF7L2 polymorphism with colorectal cancer and adenoma risk. Cancer Causes Control 2008, 19(9):975-980.
9. Folsom AR, Pankow JS, Peacock JM, Bielinski SJ, Heiss G, Boerwinkle E. Variation in TCF7L2 and increased risk of colon cancer: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 2008, 31(5):905-909. 10.2337/dc07-2131, 2577771, 18268068.
10. Slattery ML, Folsom AR, Wolff R, Herrick J, Caan BJ, Potter JD. Transcription factor 7-like 2 polymorphism and colon cancer. Cancer Epidemiol Biomarkers Prev 2008, 17(4):978-982. 10.1158/1055-9965.EPI-07-2687, 2587179, 18398040.
11. Wang X, Goode EL, Fredericksen ZS, Vierkant RA, Pankratz VS, Liu-Mares W, Rider DN, Vachon CM, Cerhan JR, Olson JE. Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2008, 17(8):2101-2108. 10.1158/1055-9965.EPI-08-0134, 18708403.
12. Kelemen LE, Sellers TA, Schildkraut JM, Cunningham JM, Vierkant RA, Pankratz VS, Fredericksen ZS, Gadre MK, Rider DN, Liebow M. Genetic variation in the one-carbon transfer pathway and ovarian cancer risk. Cancer Res 2008, 68(7):2498-2506. 10.1158/0008-5472.CAN-07-5165, 18381459.
13. Bosse Y, Bacot F, Montpetit A, Rung J, Qu HQ, Engert JC, Polychronakos C, Hudson TJ, Froguel P, Sladek R. Identification of susceptibility genes for complex diseases using pooling-based genome-wide association scans. Hum Genet 2009, 125(3):305-318. 10.1007/s00439-009-0626-9, 19184112.
14. Stolerman ES, Manning AK, McAteer JB, Fox CS, Dupuis J, Meigs JB, Florez JC. TCF7L2 variants are associated with increased proinsulin/insulin ratios but not obesity traits in the Framingham Heart Study. Diabetologia 2009, 52(4):614-620. 10.1007/s00125-009-1266-2, 19183934.
15. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature 2005, 434(7035):843-850. 10.1038/nature03319, 15829953.
16. Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein B, Kinzler KW. APC mutations occur early during colorectal tumorigenesis. Nature 1992, 359(6392):235-237. 10.1038/359235a0, 1528264.
17. Ozaki S, Ikeda S, Ishizaki Y, Kurihara T, Tokumoto N, Iseki M, Arihiro K, Kataoka T, Okajima M, Asahara T. Alterations and correlations of the components in the Wnt signaling pathway and its target genes in breast cancer. Oncol Rep 2005, 14(6):1437-1443.
18. Gerstein AV, Almeida TA, Zhao G, Chess E, Shih Ie M, Buhler K, Pienta K, Rubin MA, Vessella R, Papadopoulos N. APC/CTNNB1 (beta-catenin) pathway alterations in human prostate cancers. Genes Chromosomes Cancer 2002, 34(1):9-16. 10.1002/gcc.10037, 11921277.
19. Kurman RJ, Shih Ie M. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol 2008, 27(2):151-160.
20. Badiglian Filho L, Oshima CT, De Oliveira Lima F, De Oliveira Costa H, De Sousa Damiao R, Gomes TS, Goncalves WJ. Canonical and noncanonical Wnt pathway: A comparison among normal ovary, benign ovarian tumor and ovarian cancer. Oncol Rep 2009, 21(2):313-320.
21. Gatcliffe TA, Monk BJ, Planutis K, Holcombe RF. Wnt signaling in ovarian tumorigenesis. Int J Gynecol Cancer 2008, 18(5):954-962. 10.1111/j.1525-1438.2007.01127.x, 2575063, 17986238.